Navigation Links
Suboxone Fast Passing Methadone As Preferred Method Of Treatment For Opiate Detox
Date:11/1/2008

While Methadone treatment still holds the #1 position among detox procedures for opiate addiction, there is a new contender moving up in prominence with each passing day: Suboxone.

Palm Beach, FL (PRWEB) November 1, 2008 -- The primary reason for Suboxone's rise to prominence - as well as facilities such as Meditox of Palm Beach that offer it? The drug can be prescribed like any medication and taken at home in a private environment.

With thousands of people every day becoming addicted to opiates such as heroin and prescription painkillers, cutting-edge drug detox procedures like the ones currently offered at Medtiox of Palm Beach are a welcome sight.

Meditox uses Suboxone treatment to help individuals detoxify from opiate-based drugs. Suboxone is leading the way among new and innovative treatment methods for addiction and has already helped countless people break the cycle of drug dependence with minimal withdrawal symptoms.

What makes Meditox Treatment Program and Suboxone different?

In the past, individuals who wish to detoxify from opiates have had two choices: going it alone, cold-turkey and fall prey to the withdrawal symptoms that can lead to relapse, or disrupt their schedules and travel every day to a methadone clinic and receive a doctor-administered dose of the synthetic opiate. Now, Meditox Detox Center is leading the way with a better solution to drug detox: Suboxone.

Suboxone allows individuals to administer their own detox medication in the comfort of their own home. All they need to do is schedule a consultation at the Meditox detox facility, visit the office once for a thorough evaluation, and then begin taking your medication. With '/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. NHSA: Head Start Community Mourns Passing of Pioneer Dr. Julius Richmond
2. APHA Urges House to Protect Health of Americans by Passing Tobacco Legislation
3. Kidney Community Thanks Congress for Passing Landmark End Stage Renal Disease (ESRD) Reform
4. Veterans Mourn the Passing of Dr. Michael DeBakey
5. Home Oxygen Care Leaders Applaud U.S. Senate for Passing Medicare Bill to Improve and Protect Home Oxygen Benefit
6. Eatn Park Restaurants - States Largest Family Dining Chain - Congratulates Pennsylvania House and Senate for Passing Smoking Ban
7. Osteotech Announces the Unexpected Passing of Audit Committee Member Leads to Receipt of Nasdaq Deficiency Letter
8. Bioniche Reports the Passing of its Board Chair
9. Anniversary of Parents Passing Can Trigger Death
10. Herley Industries Announces the Passing of Its Former President
11. Drug Helps Prevent Breast-Feeding Moms From Passing on HIV
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Blood Thinner Combos Risky for Heart Attack Patients 2Health News:Centegra Expands H1N1 Vaccines to General Public 2Health News:Centegra Expands H1N1 Vaccines to General Public 3Health News:Centegra Expands H1N1 Vaccines to General Public 4Health News:Do Charitable Gift Donations Make a Difference? 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 3Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 5Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 6Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 7Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 8Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 9Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 10Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 11Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 12Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 13Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 14Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 15Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 16Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 2Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 3Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 4Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 5Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 6
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 1Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 2Indiana Home Health Agency Pays Nearly 242 Million to Settle False Claims Act Allegations 59819 1Hologic to Present at Citis 2009 Sixth Annual Small Mid Cap Conference 5609 1